Clinical Trials Browser

Phase 1 × Not yet recruiting × Clear all

NCT07509034 2026-05-27

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Phase 1 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT07572136 2026-05-27

Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07608627 2026-05-27

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07609706 2026-05-27

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

Phase 1 Not yet recruiting

Multiple Myeloma

NCT07610148 2026-05-27

A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants

Phase 1 Not yet recruiting

Breast Neoplasms

NCT07176975 2026-05-26

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

Phase 1 Not yet recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06946680 2026-05-22

Peds IMPACT

Phase 1 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioblastoma, Glioma

NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Phase 1 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07495293 2026-05-22

Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07600749 2026-05-22

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

Phase 1 Not yet recruiting

Neoplasms

NCT07601243 2026-05-22

Study of GS-2426 in Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07601334 2026-05-22

Safety and Activity of HF50 in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07601620 2026-05-22

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer

Phase 1 Not yet recruiting

Breast Neoplasms

NCT07603479 2026-05-22

A Phase I Study of JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

Lymphoma, Non-Hodgkin, Neoplasms

NCT07603596 2026-05-22

Opioid-free Anesthesia and Postoperative Delirium

Phase 1 Not yet recruiting

Gastrointestinal

Emergence Delirium, Digestive System Neoplasms

NCT05976555 2026-05-20

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma

NCT07500298 2026-05-20

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

Phase 1 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07549464 2026-05-20

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07600554 2026-05-20

SWAP

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07596381 2026-05-19

FAK Inhibitor in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07014878 2026-05-18

A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalThoracic

Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07224776 2026-05-18

Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria

Phase 1 Not yet recruiting

Neoplasms, Proteinuria

NCT07316686 2026-05-18

Lutécio

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07593092 2026-05-18

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT07593144 2026-05-18

A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07594067 2026-05-18

TCR1188-ABC Cells in KRAS-mutated Cancers

Phase 1 Not yet recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Cholangiocarcinoma

NCT07594548 2026-05-18

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Phase 1 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT07411586 2026-05-15

Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07590583 2026-05-15

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

Phase 1 Not yet recruiting

Advanced Hormone Receptor-Positive Breast Carcinoma

NCT07591155 2026-05-15

A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07591285 2026-05-15

A Study of SYS6051 in Subjects With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT07451054 2026-05-14

CD45BE-HSPC + CART-45 Cells

Phase 1 Not yet recruiting

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07581509 2026-05-14

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

Phase 1 Not yet recruiting

Melanoma

NCT07586618 2026-05-14

ALT-101

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07587827 2026-05-14

ODI-2001-01

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

NCT06549751 2026-05-13

PANACEA

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1 Not yet recruiting

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07101328 2026-05-13

BAF_FRontier-1

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07156227 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Phase 1 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07332507 2026-05-13

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Phase 1 Not yet recruiting

Plasmablastic Lymphoma

NCT07422363 2026-05-13

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Phase 1 Not yet recruiting

Glioblastoma, Gliosarcoma

NCT07444710 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Phase 1 Not yet recruiting

Ann Arbor Stage II Mantle Cell Lymphoma

NCT07573111 2026-05-13

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Phase 1 Not yet recruiting

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07582822 2026-05-13

JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07583212 2026-05-13

Phase I Study of HRS-1635 in B-cell Malignancies

Phase 1 Not yet recruiting

B-cell Malignancy

NCT07583303 2026-05-13

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07583316 2026-05-13

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis